The Effect of Compression Stockings on the Complaints of Pregnant Women With Restless Leg Syndrome
1 other identifier
interventional
70
1 country
2
Brief Summary
The aim of this project is to determine the effect of compression stockings on the complaints, well-being and sleep quality of pregnant women with restless legs syndrome (RLS). The research is a pretest-posttest randomized placebo-controlled experimental study. The study will be carried out with a total of 70 people, 35 in the compression stocking group and 35 in the placebo stocking group. Study data will be collected with RLS Diagnostic Criteria Questionnaire Form, Research Criteria Compliance Form, Personal Information Form, RLS Severity Rating Scale, Pittsburgh Sleep Quality Index (PUKI), WHO-5 and Implementation Satisfaction Form. Pregnant women in both groups will wear the stockings given for three weeks after the first interview. Data analysis obtained in the research will be performed in TURCOSA statistical software (Turcosa Analytics Ltd Co, Turkey, www.turcosa.com.tr).In comparisons, a value of p \<0.05 will be considered statistically significant. In order to conduct the study, the necessary Academic Committee decision, Ethics Committee approval (December 08, 2021 and number 2021/781) and institutional permission were obtained. The individuals included in the study will be informed about the purpose of the research, their verbal consent will be obtained and the participant's informed consent form will be signed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2022
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 20, 2023
CompletedFirst Submitted
Initial submission to the registry
March 21, 2023
CompletedFirst Posted
Study publicly available on registry
April 3, 2023
CompletedApril 3, 2023
March 1, 2023
5 days
March 21, 2023
March 21, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
RLS Severity Rating Scale
The RLS Severity Rating Scale was developed in 2003 by the International Restless Legs Syndrome Study Group. The scale was applied in the selection of patients and in the weekly evaluation of RLS severity. The scale comprised ten questions; each question was scored between 0 and 4. Questions 1, 2, 4, 6, 7, and 8 were related to RLS symptoms, questions 5, 9, and 10 were related to the effect of the disease on the mental state and daily social activities of patients with RLS, and question 3 was about the diagnostic criteria of RLS. The overall score indicated the RLS severity. A minimum score of 0 and a maximum score of 40 could be obtained. A score between 1 and 10 corresponded to "mild," 11-20 "moderate," 21-30 "severe," and 31-40 "very severe" RLS.
Change from baseline score at the end of 21. days
Secondary Outcomes (1)
Pittsburgh Sleep Quality Index
Change from baseline score at the end of 21. days
Other Outcomes (1)
World Health Organization-5 Index of Well-being (WHO-5)
Change from baseline score at the end of 21. days
Study Arms (2)
Compression stockings group
EXPERIMENTALPregnant women in the compression stockings group will wear the socks given for 3 weeks.
Placebo sock group
PLACEBO COMPARATORPregnant women in the placebo socks group will wear the socks given for 3 weeks.
Interventions
Pregnant women in the compression stockings group will wear the socks given for 3 weeks.
Pregnant women in the Knee socks group will wear the socks given for 3 weeks.
Eligibility Criteria
You may qualify if:
- Least literate,
- Between the ages of 18 and 40,
- At 27 and above gestational week,
- Single pregnancy,
- Presence of RLS according to the RLS Diagnostic Criteria Questionnaire Form,
- Having a severity of 11 and above according to the RLS Severity Rating Scale,
- Using Iron, Vitamin D, Magnesium and Calcium,
- Pregnant women with a hemoglobin level of 11 g/dl and above,
- Pregnant women who can wear socks all day long, except for going to sleep, will be included in the study.
You may not qualify if:
- Having a communication barrier,
- Having a risky pregnancy (risk of preterm labor, cervical insufficiency, preeclampsia, polyhydramnios, macrosomic baby, etc.),
- Having RLS before pregnancy,
- Having a chronic disease (Diabetes, hypertension, thyroid, cardiovascular disease, etc.),
- With maternal obesity (BMI\>30)
- Having sleep apnea before pregnancy,
- Having any psychiatric disease and using antipsychotic and antidepressant drugs,
- Using heparin, antihistamine, antiemetic, calcium channel blocker, dextromethorphan and decongestant type drugs,
- Having a dermatological problem in the feet and legs,
- Pregnant women with varicose veins on their feet and legs will not be included in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Özlem Kaplan
Kayseri, 38280, Turkey (Türkiye)
Erciyes University
Kayseri, Turkey (Türkiye)
Related Publications (1)
Kaplan O, Baser M, Ozgun MT. The effect of compression stockings on the complaints well-being and sleep quality of pregnant women with restless legs syndrome: a randomized controlled study. Rev Assoc Med Bras (1992). 2024 Aug 16;70(7):e20240145. doi: 10.1590/1806-9282.20240145. eCollection 2024.
PMID: 39166663DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Reserch Asistant
Study Record Dates
First Submitted
March 21, 2023
First Posted
April 3, 2023
Study Start
April 25, 2022
Primary Completion
April 30, 2022
Study Completion
March 20, 2023
Last Updated
April 3, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share
Will be shared after the study ends.